by GlobeNewsWire | Sep 6, 2016 | Globe Newswire
San Francisco, Sept. 06, 2016 (GLOBE NEWSWIRE) — Global cholera vaccines market is expected to reach over USD 1.25 billion by 2024, according to a new report by Grand View Research, Inc. The presence of wide range of promising vaccine candidates in the pipeline...
by GlobeNewsWire | Sep 1, 2016 | Globe Newswire
REDWOOD CITY, Calif., Sept. 01, 2016 (GLOBE NEWSWIRE) — OncoMed Pharmaceuticals Inc. (NASDAQ:OMED), a clinical development-stage biopharmaceutical company focused on discovering and developing novel anti-cancer stem cell and immuno-oncology therapeutics, today...
by GlobeNewsWire | Aug 30, 2016 | Globe Newswire
REDWOOD CITY, Calif., Aug. 30, 2016 (GLOBE NEWSWIRE) — OncoMed Pharmaceuticals Inc. (NASDAQ:OMED), a clinical development-stage biopharmaceutical company focused on discovering and developing novel anti-cancer stem cell and immuno-oncology therapeutics, today...
by GlobeNewsWire | Aug 24, 2016 | Globe Newswire
RANCHO CORDOVA, Calif., Aug. 24, 2016 (GLOBE NEWSWIRE) — Cesca Therapeutics Inc. (NASDAQ:KOOL), an autologous cell-based regenerative medicine company, today announced that the Company has converted a senior secured three year convertible debenture of $12.5...
by GlobeNewsWire | Aug 24, 2016 | Canadian Stocks, Globe Newswire
Boca Raton, Aug. 24, 2016 (GLOBE NEWSWIRE) — Earth Science Tech, Inc. (ETST) (the “Company”), a publicly traded biotechnology company that develops, produces and sells nutraceutical products along with is its leading High Grade Hemp CBD (Cannabidiol) Oil,...